Quetiapine fumarate (Seroquel) SR
Phase 3Completed 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Affective Psychosis, Bipolar
Conditions
Affective Psychosis, Bipolar, Depression, Bipolar, Manic-Depressive Psychosis, Psychoses, Manic-Depressive
Trial Timeline
Dec 1, 2006 → Jun 1, 2007
NCT ID
NCT00422214About Quetiapine fumarate (Seroquel) SR
Quetiapine fumarate (Seroquel) SR is a phase 3 stage product being developed by AstraZeneca for Affective Psychosis, Bipolar. The current trial status is completed. This product is registered under clinical trial identifier NCT00422214. Target conditions include Affective Psychosis, Bipolar, Depression, Bipolar, Manic-Depressive Psychosis.
What happened to similar drugs?
2 of 7 similar drugs in Affective Psychosis, Bipolar were approved
Approved (2) Terminated (0) Active (5)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00422123 | Phase 3 | Completed |
| NCT00422214 | Phase 3 | Completed |
Competing Products
14 competing products in Affective Psychosis, Bipolar
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Haloperidol + Olanzapine | Eli Lilly | Approved | 43 |
| Lurasidone HCl | Sumitomo Pharma | Phase 1 | 29 |
| Paliperidone ER | Johnson & Johnson | Phase 3 | 40 |
| Placebo + Paliperidone ER + Paliperidone ER | Johnson & Johnson | Phase 3 | 40 |
| Paliperidone ER + Paliperidone ER + Placebo | Johnson & Johnson | Phase 3 | 40 |
| Quetiapine fumarate (Seroquel) SR | AstraZeneca | Phase 3 | 40 |
| RO6889450 + Placebo + Risperidone | Roche | Phase 2 | 35 |
| RO6889450 + Placebo | Roche | Phase 2 | 27 |
| AMG 581 + Placebo + Midazolam | Amgen | Phase 1 | 29 |
| AMG 581 + Placebo | Amgen | Phase 1 | 29 |
| Aripiprazole + Olanzapine + Risperidone + Quetiapine + Ziprasidone + Aripiprazole + Olanzapine + Risperidone + Quetiapine + Ziprasidone | Pfizer | Phase 3 | 40 |
| Ziprasidone | Pfizer | Approved | 43 |
| ziprasidone | Pfizer | Pre-clinical | 26 |
| Ziprasidone + Sertraline + Haloperidol | Pfizer | Phase 2/3 | 38 |